Exscientia Gestion
Gestion contrôle des critères 1/4
Exscientia's CEO is Dave Hallett, appointed in Feb 2023, has a tenure of 1.75 years. directly owns 0.001% of the company’s shares, worth $7.35K. The average tenure of the management team and the board of directors is 1.8 years and 3.9 years respectively.
Informations clés
Dave Hallett
Directeur général
n/a
Rémunération totale
Pourcentage du salaire du PDG | n/a |
Durée du mandat du directeur général | 1.8yrs |
Propriété du PDG | 0.001% |
Durée moyenne d'occupation des postes de direction | 1.8yrs |
Durée moyenne du mandat des membres du conseil d'administration | 3.9yrs |
Mises à jour récentes de la gestion
Recent updates
Recursion's Acquisition Of Exscientia Makes Sense On Some Levels, Not Others
Aug 08Here's Why We're Watching Exscientia's (NASDAQ:EXAI) Cash Burn Situation
Jul 17Exscientia: Too Much Pessimism
Jun 10Exscientia: Drug Discovery Platform Attracting Partners And Cash
May 22Exscientia: A Strategic Hold In The AI-Driven Drug Discovery Sector (Rating Downgrade)
Feb 26Is Exscientia (NASDAQ:EXAI) In A Good Position To Invest In Growth?
Jan 11Earnings Update: Exscientia plc (NASDAQ:EXAI) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Nov 12New Forecasts: Here's What Analysts Think The Future Holds For Exscientia plc (NASDAQ:EXAI)
Aug 31We're Keeping An Eye On Exscientia's (NASDAQ:EXAI) Cash Burn Rate
Aug 25Broker Revenue Forecasts For Exscientia plc (NASDAQ:EXAI) Are Surging Higher
Jul 21Exscientia (NASDAQ:EXAI) Is In A Good Position To Deliver On Growth Plans
Apr 22We're Not Very Worried About Exscientia's (NASDAQ:EXAI) Cash Burn Rate
Dec 30The Exscientia plc (NASDAQ:EXAI) Analysts Have Been Trimming Their Sales Forecasts
Aug 31Exscientia: Using AI To Power Drug Development
Aug 15Companies Like Exscientia (NASDAQ:EXAI) Can Afford To Invest In Growth
May 29Exscientia: Drug Discovery Using AI For Sanofi And Self-Owned Pipeline
Apr 12Bullish: Analysts Just Made A Sizeable Upgrade To Their Exscientia plc (NASDAQ:EXAI) Forecasts
Jan 09PDG
Dave Hallett (55 yo)
1.8yrs
Titularisation
Dr. David Hallett, also known as Dave, Ph.D. is the Chief Operations Officer of Exscientia Limited since January 2020. He served as Chief Operating Officer at Exscientia plc since June 2022 until 2022 and...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Chief Scientific Officer | 1.8yrs | pas de données | 0.0012% $ 7.3k | |
CFO, Chief Strategy Officer & Executive Director | 4yrs | UK£1.92m | 0.062% $ 392.2k | |
Chief Technology Officer | less than a year | pas de données | 0.015% $ 96.0k | |
Vice President of Investor Relations | no data | pas de données | pas de données | |
Executive VP of Legal & Company Secretary | 1.8yrs | pas de données | pas de données | |
Executive Vice President of Corporate Development | less than a year | pas de données | pas de données | |
Chief People Officer | 2.2yrs | pas de données | pas de données | |
Chief Business Officer | no data | pas de données | pas de données | |
Executive Vice President of Precision Medicine | 1.8yrs | pas de données | pas de données | |
Interim Chief Medical Officer & Clinical Development Lead | less than a year | pas de données | pas de données |
1.8yrs
Durée moyenne de l'emploi
55yo
Âge moyen
Gestion expérimentée: EXAI's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Chief Scientific Officer | less than a year | pas de données | 0.0012% $ 7.3k | |
CFO, Chief Strategy Officer & Executive Director | 4yrs | UK£1.92m | 0.062% $ 392.2k | |
Independent Non-Executive Chairman | 3.8yrs | UK£282.03k | 0.089% $ 564.4k | |
Independent Non-Executive Director | 7.2yrs | UK£201.69k | 0.053% $ 334.4k | |
Independent Non-Executive Director | 4.5yrs | pas de données | pas de données | |
Independent Director | 1.5yrs | UK£178.86k | 0.028% $ 177.9k |
3.9yrs
Durée moyenne de l'emploi
51yo
Âge moyen
Conseil d'administration expérimenté: EXAI's board of directors are considered experienced (3.9 years average tenure).